Additionally, the expression of SLC2A3, a key glucose transporter in glycolysis, was markedly increased, indicating that UBD overexpression may facilitate glycolytic metabolism by enhancing glucose uptake in cancer cells. The gene discussed is SLC2A3; the disease is cancer.